Fostair NEXThaler (formoterol beclometasone dipropionate): Reviews and patient testimonials
Back to the list of medications
Medication indications
Fostair NEXThaler 100/6
Asthma
Fostair NEXThaler is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:
- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonist or
- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.
Fostair NEXThaler is indicated for adult patients.
Note: there are no relevant clinical data on the use of Fostair NEXThaler for the treatment of acute asthma attacks.
COPD
Symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.
Fostair NEXThaler 200/6
Fostair NEXThaler is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists. Fostair NEXThaler is indicated in adults.Note: there are no relevant clinical data on the use of Fostair NEXThaler for the treatment of acute asthma attacks.Molecule: formoterol, beclometasone dipropionate
Tips and advice of the community